Dewormer
It is used to treat flea and tick infestations on the dog's body surface, and can also assist in the treatment of allergic dermatitis caused by fleas.
Fluralaner Chewable Tablet is a systemic ectoparasiticide belonging to the isoxazoline class. It is highly effective against fleas and ticks (including multiple life stages) in dogs. While it is not a traditional Dewormer (which targets internal parasites like roundworms or tapeworms), it is often used alongside a deworming program for complete parasite control. As a reliable supplier, WERVIC offers high-quality Fluralaner Chewable Tablets with excellent palatability and proven efficacy.
For dogs with heavy flea or tick infestations.
In areas with high tick-borne disease pressure (e.g., Lyme disease, ehrlichiosis).
When pet owners prefer less frequent dosing (every 3 months instead of monthly).
As part of an integrated parasite management plan – combine with a Dewormer for internal parasites.
Fluralaner 112.5mg 250mg 500mg 1000mg 1400mg
Light brown to dark brown round piece
For dogs only
1 tablet/box or 4 tablets/box
Long-lasting protection – A single oral dose provides up to 12 weeks of flea and tick control, reducing treatment frequency.
Fast acting – Starts killing fleas within 2 hours and ticks within 4 hours.
Safe & well-tolerated – Suitable for dogs from 8 weeks of age and weighing at least 2 kg.
Waterproof & bath-proof – Efficacy is not affected by bathing or swimming after administration.
Chewable & palatable – Easy to administer without hiding in food.
GMP-certified manufacturing – Ensuring consistent quality and purity.
Competitive OEM/ODM services – Customizable packaging, flavors, and tablet strengths.
Strict quality control – Each batch tested for dissolution, potency, and stability.
Global export experience – Compliant with international veterinary standards.
Reliable supply chain – Timely delivery and responsive after-sales support.
|
Weight (kg) |
Strength |
Quantity |
|
≥2~ ≤4.5 |
112.5mg/tablet |
1 |
|
>4.5~ ≤10 |
250mg/tablet |
1 |
|
>10~ ≤20 |
500mg/tablet |
1 |
|
>20~ ≤40 |
1000mg/tablet |
1 |
|
>40~ ≤56 |
1400mg/tablet |
1 |
|
>56 |
Choose the right combination of strength. |
under medical supervision |
Can be used for breeding dogs, pregnant and lactating female dogs.
Fluralaner has a high plasma protein binding rate and may compete with other drugs with a high protein binding rate, such as non-steroidal anti-inflammatory drugs, coumarin derivative warfarin, etc. In vitro plasma incubation tests, there was no evidence of competitive plasma protein binding between fluralaner and carprofen and warfarin. The clinical trials did not find any interaction between fluralaner and the daily medication used in dogs.
In case of any serious reactions or other adverse reactions not mentioned in this manual, please consult a veterinarian in time.
This product acts quickly and can reduce the risk of trans- mission of insect-borne diseases. But fleas and ticks must contact the host and start feeding in order to be exposed to the active drug ingredient. Fleas (Ctenocephalus felis) are effective within 8 hours after exposure, and ticks (Ixodes ricinus) are effective within 12 hours after exposure. There- fore, under extremely harsh conditions, the risk of disease transmission through parasites cannot be completely ruled out.
In addition to direct feeding, this product can be mixed into the dog food for feeding, and observe the dog during administration to confirm that the dog swallows the drug.
Cautions:
This product should not be used on puppies under 8 weeks old or dogs weighing less than 2kg.
Do not use in dogs allergic to this product.
The dosing interval of this product shall not be less than 8 week.
Do not eat, drink or smoke while administering the drug. Wash hands thoroughly with soap and water immediately after contact with this product.
Keep out of reach of children.
Please check whether the package is intact before use. If it is damaged, do not use it.
Unused veterinary drugs and packaging materials should be disposed of in accordance with local egulations.
Can be used for breeding dogs, pregnant and lactating female dogs.
Fluralaner has a high plasma protein binding rate and may compete with other drugs with a high protein binding rate, such as non-steroidal anti-inflammatory drugs, coumarin derivative warfarin, etc. In vitro plasma incubation tests, there was no evidence of competitive plasma protein binding between fluralanerandcarprofen and warfarin. The clinical trials did not find any interaction between fluralaner and the daily medication used in dogs.
